Document is current
Any future updates will be listed below
-
Authors
Ejigu, Dawit Asmamaw
Fekadu, Abebaw
Whitty, Jeremy
Manyazewal, Tsegahun
Nebeta, Pamela
Conradie, Almari
Okech, Brenda
Neequaye, Alice
Whitty, Sinéad
Lehrman, Jennifer
Holt, Renee
Birhane, Rahel
Vahedi, Mahnaz
Demarest, Helen
Makonnen, Eyasu
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
Bill & Melinda Gates Foundation (INV-024950)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 21 January 2025
First Online: 24 January 2025
Declarations
:
: Scientific and Ethics Review Committee of the Center for Innovative Drug Development and Therapeutic Trials for Africa approved the study. Informed consent was obtained from the course participants for both the pre- and post-course survey and the qualitative part. The study adhered to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
